tiprankstipranks
SanBio Co Ltd (SNBIF)
OTHER OTC:SNBIF
Holding SNBIF?
Track your performance easily

SanBio Co (SNBIF) Stock Price & Analysis

11 Followers

SNBIF Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

99.71%
Insiders
― Other Institutional Investors
99.71% Public Companies and
Individual Investors

SNBIF FAQ

What was SanBio Co Ltd’s price range in the past 12 months?
SanBio Co Ltd lowest stock price was $3.53 and its highest was $6.21 in the past 12 months.
    What is SanBio Co Ltd’s market cap?
    SanBio Co Ltd’s market cap is $317.82M.
      When is SanBio Co Ltd’s upcoming earnings report date?
      SanBio Co Ltd’s upcoming earnings report date is Mar 13, 2025 which is in 43 days.
        How were SanBio Co Ltd’s earnings last quarter?
        SanBio Co Ltd released its earnings results on Dec 16, 2024. The company reported -$0.079 earnings per share for the quarter, beating the consensus estimate of -$0.118 by $0.039.
          Is SanBio Co Ltd overvalued?
          According to Wall Street analysts SanBio Co Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does SanBio Co Ltd pay dividends?
            SanBio Co Ltd does not currently pay dividends.
            What is SanBio Co Ltd’s EPS estimate?
            SanBio Co Ltd’s EPS estimate is 0.
              How many shares outstanding does SanBio Co Ltd have?
              SanBio Co Ltd has 70,927,200 shares outstanding.
                What happened to SanBio Co Ltd’s price movement after its last earnings report?
                SanBio Co Ltd reported an EPS of -$0.079 in its last earnings report, beating expectations of -$0.118. Following the earnings report the stock price went same 0%.
                  Which hedge fund is a major shareholder of SanBio Co Ltd?
                  Currently, no hedge funds are holding shares in SNBIF
                  ---

                  Company Description

                  SanBio Co Ltd

                  SanBio Co., Ltd. engages in the development, production and sale of regenerative cells medicines. It provides regenerative therapies for neurological disorders that include stroke, traumatic brain injury, eye diseases, and Parkinson's disease. The company was founded on February 27, 2013 and is headquartered in Tokyo, Japan.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Astellas Pharma
                  AnGes
                  Eisai Co
                  Otsuka Holdings Co
                  Takeda Pharmaceutical Co
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis